Evidence map›Paper›PMID 30029904›Full record

ArticleTuberculosis (Edinburgh, Scotland)2018

Deletion of PPARγ in lung macrophages provides an immunoprotective response against M. tuberculosis infection in mice.

Evelyn Guirado, Murugesan Vs Rajaram, Ajay Chawla, Joanna Daigle, Krista Md La Perle, Eusondia Arnett, Joanne Turner, Larry S Schlesinger

Open access · hybridAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. iScience · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Essential Roles of PPARs in Lipid Metabolism during Mycobacterial Infection.International journal of molecular sciences · 2021
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Evelyn GuiradoCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: evelynguirado@gmail.com.
Murugesan Vs RajaramCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: murugesan.rajaram@osumc.edu.
Ajay ChawlaCardiovascular Research Institute, University of California, San Francisco, CA, USA. Electronic address: ajay.chawla@ucsf.edu.
Joanna DaigleCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: joanna.daigle@usask.ca.
Krista Md La PerleComparative Pathology and Mouse Phenotyping Shared Resource, Department of Veterinary Biosciences, The Ohio State University, Arthur G. James Comprehensive Cancer Center, Columbus, OH, USA. Electronic address: laperle.1@osu.edu.
Eusondia ArnettCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: earnett@txbiomed.org.
Joanne TurnerCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: joanneturner@txbiomed.org.
Larry S SchlesingerCenter for Microbial Interface Biology, Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: Lschlesinger@txbiomed.org.
Interface (United States) · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUniversity of California, San Francisco · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Innate Immune Mechanisms of ThermogenesisR01DK094641 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, BIAO · 2011 to 2019
$3.5M
TB and Innate Immune Regulation of Lung MacrophagesR01AI059639 · NIAID · OHIO STATE UNIVERSITY · PI SCHLESINGER, LARRY S. · 2005 to 2016
$3.2M
Transcriptional control in brown and beige adipocytesR01DK105175 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, BIAO · 2015 to 2019
$1.8M
Myeloid Cell Functions in Obesity and Diabetes.R01DK101064 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAWLA, AJAY · 2015 to 2018
$1.6M
NCI NIH HHS P30 CA016058NIAID NIH HHS R01 AI059639NIDDK NIH HHS R01 DK094641NIDDK NIH HHS R01 DK101064NIDDK NIH HHS R01 DK105175
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear transcription factor belonging to the superfamily of ligand-activated nuclear receptors. It is activated by diverse endogenous lipid metabolites as well as by exogenous ligands such as the thiazolidinediones. It regulates cellular metabolism, proliferation, differentiation, and inflammation, the latter in part through trans-repression of pro-inflammatory cytokines. PPARγ is highly expressed in alternatively activated alveolar macrophages (AMs), a primary host cell for airborne Mycobacterium tuberculosis (M.tb). Our previous in vitro study identified the importance of PPARγ activation through the mannose receptor (CD206) on human macrophages in enabling M. tb growth. The aim of the current study was to investigate the role of PPARγ in vivo during M. tb infection using a macrophage-specific PPARγ knock out mouse model with special emphasis on the lung environment. Our data show that the absence of PPARγ in lung macrophages reduces the growth of virulent M. tb, enhances pro-inflammatory cytokines and reduces granulomatous infiltration. These findings demonstrate that PPARγ activation, which down-regulates macrophage pro-inflammatory responses, impacts the lung's response to M. tb infection, thereby supporting PPARγ's role in tuberculosis (TB) pathogenesis.

Indexed as

Gene DeletionAnimalsBacterial LoadCells, CulturedCytokinesDisease Models, AnimalHost-Pathogen InteractionsInflammation MediatorsLungMacrophages, AlveolarMice, Inbred BALB CMice, KnockoutMycobacterium tuberculosisPPAR gammaSignal TransductionTuberculosis, PulmonaryCytokinesInflammation MediatorsPPAR gammaMacrophageM. tuberculosisPPARγ

Identifiers

PMID30029904
PMCPMC6481684
OpenAlexW2808863707

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.